(Q45201623)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Gesina Hansel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Andreas Koch

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Erich Köstler

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

24 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

number of pages

5

1 reference

Journal of Cancer Research and Clinical Oncology

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

300-304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-004-0656-6

6 January 2020

exact match

0 references

cites work

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Interdisciplinary documentation of treatment side effects in oncology. Present status and perspectives.

1 reference

12 December 2020

Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer

1 reference

12 December 2020

Role of thymidine phosphorylase in biomodulation of fluoropyrimidines

1 reference

12 December 2020

Clinical experience of capecitabine in metastatic breast cancer

1 reference

12 December 2020

Rational development of capecitabine

1 reference

12 December 2020

The epidemiology of UV induced skin cancer

1 reference

12 December 2020

Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.

1 reference

12 December 2020

Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm

1 reference

12 December 2020

Cisplatin and 5-fluorouracil for metastatic squamous cell carcinoma from unknown primary.

1 reference

12 December 2020

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

12 December 2020

Capecitabine: a novel agent for the treatment of solid tumors

1 reference

12 December 2020

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts

1 reference

12 December 2020

Evaluation of patients with advanced cancer using the Karnofsky performance status

1 reference

12 December 2020

Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma

1 reference

12 December 2020

Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics

1 reference

12 December 2020

Inflammation of actinic keratoses during capecitabine therapy

1 reference

12 December 2020

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin

1 reference

12 December 2020

Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged.

1 reference

12 December 2020

Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer

1 reference

12 December 2020

Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues

1 reference

12 December 2020

The majority of cutaneous squamous cell carcinomas arise in actinic keratoses

1 reference

12 December 2020

10.1007/S00432-004-0656-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15619125%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 January 2020

1030199192

0 references

Fatcat ID

release_3koreyapqrctbc3aguobcgv5ai

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3koreyapqrctbc3aguobcgv5ai

24 November 2022

mapped directly with Wikidata item

1 reference